Compare BFC & HROW Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
Current Price
| Metric | BFC | HROW |
|---|---|---|
| Founded | 1894 | 1998 |
| Country | United States | United States |
| Employees | N/A | N/A |
| Industry | Major Banks | Biotechnology: Pharmaceutical Preparations |
| Sector | Finance | Health Care |
| Exchange | Nasdaq | Nasdaq |
| Market Cap | 1.5B | 1.7B |
| IPO Year | N/A | N/A |
| Metric | BFC | HROW |
|---|---|---|
| Price | $144.95 | $46.55 |
| Analyst Decision | Buy | Strong Buy |
| Analyst Count | 2 | 8 |
| Target Price | ★ $150.00 | $68.86 |
| AVG Volume (30 Days) | 65.1K | ★ 581.8K |
| Earning Date | 01-22-2026 | 03-16-2026 |
| Dividend Yield | ★ 1.37% | N/A |
| EPS Growth | ★ 11.19 | N/A |
| EPS | ★ 7.23 | N/A |
| Revenue | $172,628,000.00 | ★ $250,042,000.00 |
| Revenue This Year | $61.71 | $38.57 |
| Revenue Next Year | $1.23 | $42.17 |
| P/E Ratio | $20.25 | ★ N/A |
| Revenue Growth | 9.09 | ★ 47.83 |
| 52 Week Low | $93.00 | $20.85 |
| 52 Week High | $146.91 | $54.85 |
| Indicator | BFC | HROW |
|---|---|---|
| Relative Strength Index (RSI) | 73.33 | 52.49 |
| Support Level | $134.17 | $40.61 |
| Resistance Level | $141.19 | $44.05 |
| Average True Range (ATR) | 4.70 | 1.97 |
| MACD | 1.52 | -0.31 |
| Stochastic Oscillator | 95.38 | 63.42 |
Bank First Corp is a United States-based company engaged in providing financial services provides a full range of consumer and commercial financial institution services to individuals and businesses including retail and commercial banking in Wisconsin. These services include credit cards; secured and unsecured consumer, commercial, and real estate loans; demand, time, and savings deposits; and ATM processing. The Corporation also offers a full line of insurance services and checking accounts, savings accounts, money market accounts, cash management accounts, certificates of deposit, commercial and industrial loans, commercial real estate loans, construction and development loans, residential mortgages, consumer loans, credit cards, online banking, telephone banking, and mobile banking.
Harrow Inc is an eyecare pharmaceutical company engaged in the discovery, development, and commercialization of ophthalmic pharmaceutical products for the U.S. market. The company helps U.S. eyecare professionals preserve the gift of sight by making its comprehensive portfolio of prescription and non-prescription pharmaceutical products accessible and affordable to millions of Americans. Its operating segments are The Branded segment includes activities of the Company's FDA-approved ophthalmology pharmaceutical products, including the out-licensing of rights to certain of branded products; and The ImprimisRx segment represents activities in the Company's ophthalmology-focused pharmaceutical compounding business.